Publication | Open Access
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
177
Citations
21
References
2018
Year
Bayer and Janssen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1